HOME >> MEDICINE >> NEWS
Injectable drug, combined with counseling, shows promise in treating alcohol dependence

(Philadelphia, PA) -- Alcohol dependence is a major public health problem, ranking as the fourth leading cause of disability worldwide, according to the World Health Organization's Global Burden of Disease project. In the United States, it is believed to contribute to more than 100,000 preventable deaths a year. Now, researchers from the University of Pennsylvania School of Medicine, in conjunction with 23 other sites nationwide, have found that long-acting injections of the drug naltrexone, when added to counseling, significantly reduced heavy drinking in patients being treated for alcohol dependence.

Study results show that the median number of heavy-drinking days was reduced from 19 days in the month prior to the study to three days per month over the six months of treatment. The results will be published in the April 6 issue of the Journal of the American Medical Association.

"It is so important that our field find new treatments for alcohol dependence," says Helen Pettinati, PhD, Research Professor in Penn's Department of Psychiatry, Director, Treatment Research Division in the Center for the Study of Addictions, and lead investigator for Penn's component of the trial. "Long-acting naltrexone represents a promising new development for treatment, and I hope that it can play a role in helping the large number of individuals in the U.S. who suffer from alcohol dependence."

Naltrexone was approved in pill form by the U.S. Food and Drug Administration in 1994 for treating alcohol dependence. It belongs to a class of drugs called opioid antagonists, for treating alcohol dependence. Although many clinical trials have shown that oral naltrexone can be effective in treating alcohol dependence, its use in clinical practice has been limited, in part because the drug was given as a pill that patients have to take daily.

"Alcoholism is a serious disease that destroys lives. As we learn more about how the brain is affected by alcohol, we are disc
'"/>

Contact: Ed Federico
ed.federico@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
5-Apr-2005


Page: 1 2

Related medicine news :

1. Mistletoe is not an anti-cancer drug, say doctors
2. RAND study shows solitary drug, alcohol and cigarette use puts adolescents at higher risk
3. The Journal of Clinical Pharmacology looks at effects of smoking cessation drug, varenicline
4. Stubborn ulcerative colitis responds to arthritis drug, review finds
5. Brain power combined to form new $125M institute
6. New study demonstrates combined techniques to detect, monitor Alzheimers disease
7. TPV EU approval provides new HIV active drug to be combined with FUZEON
8. 1.7m to build worlds first SIMS instrument combined with infra-red spectroscopy
9. Antibody combined with cancer drug shows promise against breast tumors
10. Targeted cancer drug combined with low-dose chemotherapy shrinks tumors, slows ovarian cancer
11. Medication combined with behavior therapy works best for ADHD children, study finds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... ... CentrAlert, Inc. today announced the launch of their free Know ... which is available for Apple and Android , seeks to streamline ... , “When COVID-19 first hit, there was so much that we didn’t know,” says ...
(Date:8/5/2020)... (PRWEB) , ... August 04, 2020 , ... ... adults living with memory impairment, has announced the Best Memory Care Facilities in ... to experts, facility features and amenities. , According to the Alzheimer’s ...
(Date:8/3/2020)... ... August 03, 2020 , ... WorkBook6 – a Tempe, ... CoverageCoach. The site provides a simple and efficient way for Americans over the ... CoverageCoach as an important expansion for the insurance marketing ecosystem, and a critical ...
(Date:7/31/2020)... , ... July 31, 2020 , ... ... Meridian Clinical Research’s internal medicine site in Savannah, GA. Visitors included ... OWS. , In May, the federal government announced the OWS program to accelerate ...
(Date:7/31/2020)... , ... July 31, 2020 , ... ... C. Anderson issued the following statement today regarding the nation’s ongoing preparations for ... patients and the nation with an efficient, effective and essential component of vaccine ...
Breaking Medicine News(10 mins):
(Date:7/31/2020)... ... 2020 , ... Innovative Health, Inc. today announced ... Needle and the Baylis Medical NRG Transseptal Needle. Innovative Health’s clearance to reprocess ... other company is able to offer reprocessed transseptal needles and unlock additional savings ...
(Date:7/31/2020)... ... July 31, 2020 , ... Member Care Solutions announced a deal ... care clinic operators the licensing of their cloud based membership management software platform. , ... client family. Our software is the perfect match for many reasons, but AFC’s need ...
(Date:7/31/2020)... LOS ANGELES (PRWEB) , ... July 31, 2020 , ... ... generations where tooth decay was believed to have been caused by tiny worms that ... have led to this myth including details of small creatures that are commonly found ...
Breaking Medicine Technology:
Cached News: